Inventing new therapies without reinventing the wheel: the power of drug repurposing.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

44 citing papers in PubMed.

1. Repurposing T-type calcium channel blocker lomerizine as a therapeutic strategy for glioblastoma.JCI insight · 2026
   Article
2. Drug-Induced Phospholipidosis as an Artifact in Antiviral Drug Repurposing.ACS omega · 2026
   Article
3. Drug-induced phospholipidosis as an artifact in antiviral drug repurposing.bioRxiv : the preprint server for biology · 2025
   Article
4. Dynamic clinical trial success rates for drugs in the 21st century.Nature communications · 2025
   Article
5. The microbiota-gut-brain-axis theory: role of gut microbiota modulators (GMMs) in gastrointestinal, neurological, and mental health disorders.Naunyn-Schmiedeberg's archives of pharmacology · 2025
   Review
6. New insights on Drug's design against candidiasis on the fructose biphosphate aldolase (Fba1) and the pyruvate kinase (Pk) ofBiochemistry and biophysics reports · 2025
   Article
7. Discovery of novel antifungal drugs via screening repurposing libraries againstmBio · 2025
   Article
8. Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer's disease.Frontiers in aging neuroscience · 2025
   Review
9. Drug repurposing for glomerular diseases: an underutilized resource.Nature reviews. Nephrology · 2024
   Review
10. Predictions of Colloidal Molecular Aggregation Using AI/ML Models.ACS omega · 2024
    Article
11. Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients.Cancers · 2024
    Review
12. Colloidal Aggregation Confounds Cell-Based Covid-19 Antiviral Screens.Journal of medicinal chemistry · 2024
    Article
13. Colloidal aggregation confounds cell-based Covid-19 antiviral screens.bioRxiv : the preprint server for biology · 2023
    Article
14. Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Article
15. Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells.Frontiers in oncology · 2023
    Article
16. Repurposed Drugs in Gastric Cancer.Molecules (Basel, Switzerland) · 2022
    Review
17. Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
18. The Role of Hidden Conformers in Determination of Conformational Preferences of Mefenamic Acid by NOESY Spectroscopy.Pharmaceutics · 2022
    Article
19. Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases.Cancers · 2022
    Review
20. Structural Comparison of Sulfonamide-Based Derivatives That Can Improve Anti-Coagulation Properties of Metformin.International journal of molecular sciences · 2022
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as